Grifols, S.A. reported €7.52B of revenue over the trailing twelve months, +4.3% on the year before. 10 reported series are charted on this page, each one as filed. Revenue, trailing twelve months: €7.52B (to FY2025). Net income: €402M, trailing twelve months to FY2025. Free cash flow: €782M, trailing twelve months to FY2025. Operating margin: 17%, trailing twelve months to FY2025.

GRFSGrifols, S.A.

Healthcare

$7.54-23% 1Y

$7.54

$7.0052 weeks$9.72

GRFS as reported

Grifols, S.A. reported €7.52B of revenue over the trailing twelve months, +4.3% on the year before. 10 reported series are charted on this page, each one as filed.

€7.52B

Revenue, trailing twelve months · to FY2025 · +4.3% against the twelve months before

Net income: €402M
Net income · +156% year on year · trailing twelve months to FY2025
Free cash flow: €782M
Free cash flow · +17% year on year · trailing twelve months to FY2025
Operating margin: 17%
Operating margin · trailing twelve months to FY2025

Details›

Every series Ryufin has for GRFS, trailing twelve months
Series	Latest	Year on year	As of
Revenue	€7.52B	+4.3%	FY2025
Net income	€402M	+156%	FY2025
EPS	€0.59	+157%	FY2025
Gross margin	38%	n/a	FY2025
Operating margin	17%	n/a	FY2025
Net margin	5.3%	n/a	FY2025
ROE	7.6%	n/a	FY2025
ROA	2.0%	n/a	FY2025
ROIC	15%	n/a	FY2025
Free cash flow	€782M	+17%	FY2025

Every figure straight from the statements filed with the SEC, no scoring. Per-share figures and share counts are restated for stock splits, so a split never shows up as a collapse. Open a series for its full history.